Global Vascular Disrupting Agents Supply, Demand and Key Producers, 2023-2029
The global Vascular Disrupting Agents market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
This report studies the global Vascular Disrupting Agents production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Vascular Disrupting Agents, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Vascular Disrupting Agents that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Vascular Disrupting Agents total production and demand, 2018-2029, (K Units)
Global Vascular Disrupting Agents total production value, 2018-2029, (USD Million)
Global Vascular Disrupting Agents production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Vascular Disrupting Agents consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Vascular Disrupting Agents domestic production, consumption, key domestic manufacturers and share
Global Vascular Disrupting Agents production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Vascular Disrupting Agents production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Vascular Disrupting Agents production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Vascular Disrupting Agents market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AGC Biologics, Avid Bioservices, Bionomics, Beijing Shenogen Biomedical, Mateon Therapeutics, Myrexis, VBL Therapeutics, Steba biotech and BeyondSpring Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Vascular Disrupting Agents market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Vascular Disrupting Agents Market, By Region:
1. How big is the global Vascular Disrupting Agents market?
2. What is the demand of the global Vascular Disrupting Agents market?
3. What is the year over year growth of the global Vascular Disrupting Agents market?
4. What is the production and production value of the global Vascular Disrupting Agents market?
5. Who are the key producers in the global Vascular Disrupting Agents market?
6. What are the growth factors driving the market demand?
This report studies the global Vascular Disrupting Agents production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Vascular Disrupting Agents, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Vascular Disrupting Agents that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Vascular Disrupting Agents total production and demand, 2018-2029, (K Units)
Global Vascular Disrupting Agents total production value, 2018-2029, (USD Million)
Global Vascular Disrupting Agents production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Vascular Disrupting Agents consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Vascular Disrupting Agents domestic production, consumption, key domestic manufacturers and share
Global Vascular Disrupting Agents production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Vascular Disrupting Agents production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Vascular Disrupting Agents production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Vascular Disrupting Agents market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AGC Biologics, Avid Bioservices, Bionomics, Beijing Shenogen Biomedical, Mateon Therapeutics, Myrexis, VBL Therapeutics, Steba biotech and BeyondSpring Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Vascular Disrupting Agents market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Vascular Disrupting Agents Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Oral
- Vein
- Hospital
- Specialty Clinic
- Others
- AGC Biologics
- Avid Bioservices
- Bionomics
- Beijing Shenogen Biomedical
- Mateon Therapeutics
- Myrexis
- VBL Therapeutics
- Steba biotech
- BeyondSpring Pharmaceutical
- Immune Pharmaceuticals
- Nereus Pharmaceuticals
- Madrigal Pharmaceuticals
- Celgene Corporation
- Bionomics
- Lees Pharmaceutical Holdings
1. How big is the global Vascular Disrupting Agents market?
2. What is the demand of the global Vascular Disrupting Agents market?
3. What is the year over year growth of the global Vascular Disrupting Agents market?
4. What is the production and production value of the global Vascular Disrupting Agents market?
5. Who are the key producers in the global Vascular Disrupting Agents market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Vascular Disrupting Agents Introduction
1.2 World Vascular Disrupting Agents Supply & Forecast
1.2.1 World Vascular Disrupting Agents Production Value (2018 & 2022 & 2029)
1.2.2 World Vascular Disrupting Agents Production (2018-2029)
1.2.3 World Vascular Disrupting Agents Pricing Trends (2018-2029)
1.3 World Vascular Disrupting Agents Production by Region (Based on Production Site)
1.3.1 World Vascular Disrupting Agents Production Value by Region (2018-2029)
1.3.2 World Vascular Disrupting Agents Production by Region (2018-2029)
1.3.3 World Vascular Disrupting Agents Average Price by Region (2018-2029)
1.3.4 North America Vascular Disrupting Agents Production (2018-2029)
1.3.5 Europe Vascular Disrupting Agents Production (2018-2029)
1.3.6 China Vascular Disrupting Agents Production (2018-2029)
1.3.7 Japan Vascular Disrupting Agents Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Vascular Disrupting Agents Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Vascular Disrupting Agents Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Vascular Disrupting Agents Demand (2018-2029)
2.2 World Vascular Disrupting Agents Consumption by Region
2.2.1 World Vascular Disrupting Agents Consumption by Region (2018-2023)
2.2.2 World Vascular Disrupting Agents Consumption Forecast by Region (2024-2029)
2.3 United States Vascular Disrupting Agents Consumption (2018-2029)
2.4 China Vascular Disrupting Agents Consumption (2018-2029)
2.5 Europe Vascular Disrupting Agents Consumption (2018-2029)
2.6 Japan Vascular Disrupting Agents Consumption (2018-2029)
2.7 South Korea Vascular Disrupting Agents Consumption (2018-2029)
2.8 ASEAN Vascular Disrupting Agents Consumption (2018-2029)
2.9 India Vascular Disrupting Agents Consumption (2018-2029)
3 WORLD VASCULAR DISRUPTING AGENTS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Vascular Disrupting Agents Production Value by Manufacturer (2018-2023)
3.2 World Vascular Disrupting Agents Production by Manufacturer (2018-2023)
3.3 World Vascular Disrupting Agents Average Price by Manufacturer (2018-2023)
3.4 Vascular Disrupting Agents Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Vascular Disrupting Agents Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Vascular Disrupting Agents in 2022
3.5.3 Global Concentration Ratios (CR8) for Vascular Disrupting Agents in 2022
3.6 Vascular Disrupting Agents Market: Overall Company Footprint Analysis
3.6.1 Vascular Disrupting Agents Market: Region Footprint
3.6.2 Vascular Disrupting Agents Market: Company Product Type Footprint
3.6.3 Vascular Disrupting Agents Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Vascular Disrupting Agents Production Value Comparison
4.1.1 United States VS China: Vascular Disrupting Agents Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Vascular Disrupting Agents Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Vascular Disrupting Agents Production Comparison
4.2.1 United States VS China: Vascular Disrupting Agents Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Vascular Disrupting Agents Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Vascular Disrupting Agents Consumption Comparison
4.3.1 United States VS China: Vascular Disrupting Agents Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Vascular Disrupting Agents Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Vascular Disrupting Agents Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Vascular Disrupting Agents Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Vascular Disrupting Agents Production Value (2018-2023)
4.4.3 United States Based Manufacturers Vascular Disrupting Agents Production (2018-2023)
4.5 China Based Vascular Disrupting Agents Manufacturers and Market Share
4.5.1 China Based Vascular Disrupting Agents Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Vascular Disrupting Agents Production Value (2018-2023)
4.5.3 China Based Manufacturers Vascular Disrupting Agents Production (2018-2023)
4.6 Rest of World Based Vascular Disrupting Agents Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Vascular Disrupting Agents Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Vascular Disrupting Agents Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Vascular Disrupting Agents Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Vascular Disrupting Agents Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Oral
5.2.2 Vein
5.3 Market Segment by Type
5.3.1 World Vascular Disrupting Agents Production by Type (2018-2029)
5.3.2 World Vascular Disrupting Agents Production Value by Type (2018-2029)
5.3.3 World Vascular Disrupting Agents Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Vascular Disrupting Agents Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Specialty Clinic
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Vascular Disrupting Agents Production by Application (2018-2029)
6.3.2 World Vascular Disrupting Agents Production Value by Application (2018-2029)
6.3.3 World Vascular Disrupting Agents Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 AGC Biologics
7.1.1 AGC Biologics Details
7.1.2 AGC Biologics Major Business
7.1.3 AGC Biologics Vascular Disrupting Agents Product and Services
7.1.4 AGC Biologics Vascular Disrupting Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 AGC Biologics Recent Developments/Updates
7.1.6 AGC Biologics Competitive Strengths & Weaknesses
7.2 Avid Bioservices
7.2.1 Avid Bioservices Details
7.2.2 Avid Bioservices Major Business
7.2.3 Avid Bioservices Vascular Disrupting Agents Product and Services
7.2.4 Avid Bioservices Vascular Disrupting Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Avid Bioservices Recent Developments/Updates
7.2.6 Avid Bioservices Competitive Strengths & Weaknesses
7.3 Bionomics
7.3.1 Bionomics Details
7.3.2 Bionomics Major Business
7.3.3 Bionomics Vascular Disrupting Agents Product and Services
7.3.4 Bionomics Vascular Disrupting Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Bionomics Recent Developments/Updates
7.3.6 Bionomics Competitive Strengths & Weaknesses
7.4 Beijing Shenogen Biomedical
7.4.1 Beijing Shenogen Biomedical Details
7.4.2 Beijing Shenogen Biomedical Major Business
7.4.3 Beijing Shenogen Biomedical Vascular Disrupting Agents Product and Services
7.4.4 Beijing Shenogen Biomedical Vascular Disrupting Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Beijing Shenogen Biomedical Recent Developments/Updates
7.4.6 Beijing Shenogen Biomedical Competitive Strengths & Weaknesses
7.5 Mateon Therapeutics
7.5.1 Mateon Therapeutics Details
7.5.2 Mateon Therapeutics Major Business
7.5.3 Mateon Therapeutics Vascular Disrupting Agents Product and Services
7.5.4 Mateon Therapeutics Vascular Disrupting Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Mateon Therapeutics Recent Developments/Updates
7.5.6 Mateon Therapeutics Competitive Strengths & Weaknesses
7.6 Myrexis
7.6.1 Myrexis Details
7.6.2 Myrexis Major Business
7.6.3 Myrexis Vascular Disrupting Agents Product and Services
7.6.4 Myrexis Vascular Disrupting Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Myrexis Recent Developments/Updates
7.6.6 Myrexis Competitive Strengths & Weaknesses
7.7 VBL Therapeutics
7.7.1 VBL Therapeutics Details
7.7.2 VBL Therapeutics Major Business
7.7.3 VBL Therapeutics Vascular Disrupting Agents Product and Services
7.7.4 VBL Therapeutics Vascular Disrupting Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 VBL Therapeutics Recent Developments/Updates
7.7.6 VBL Therapeutics Competitive Strengths & Weaknesses
7.8 Steba biotech
7.8.1 Steba biotech Details
7.8.2 Steba biotech Major Business
7.8.3 Steba biotech Vascular Disrupting Agents Product and Services
7.8.4 Steba biotech Vascular Disrupting Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Steba biotech Recent Developments/Updates
7.8.6 Steba biotech Competitive Strengths & Weaknesses
7.9 BeyondSpring Pharmaceutical
7.9.1 BeyondSpring Pharmaceutical Details
7.9.2 BeyondSpring Pharmaceutical Major Business
7.9.3 BeyondSpring Pharmaceutical Vascular Disrupting Agents Product and Services
7.9.4 BeyondSpring Pharmaceutical Vascular Disrupting Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 BeyondSpring Pharmaceutical Recent Developments/Updates
7.9.6 BeyondSpring Pharmaceutical Competitive Strengths & Weaknesses
7.10 Immune Pharmaceuticals
7.10.1 Immune Pharmaceuticals Details
7.10.2 Immune Pharmaceuticals Major Business
7.10.3 Immune Pharmaceuticals Vascular Disrupting Agents Product and Services
7.10.4 Immune Pharmaceuticals Vascular Disrupting Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Immune Pharmaceuticals Recent Developments/Updates
7.10.6 Immune Pharmaceuticals Competitive Strengths & Weaknesses
7.11 Nereus Pharmaceuticals
7.11.1 Nereus Pharmaceuticals Details
7.11.2 Nereus Pharmaceuticals Major Business
7.11.3 Nereus Pharmaceuticals Vascular Disrupting Agents Product and Services
7.11.4 Nereus Pharmaceuticals Vascular Disrupting Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Nereus Pharmaceuticals Recent Developments/Updates
7.11.6 Nereus Pharmaceuticals Competitive Strengths & Weaknesses
7.12 Madrigal Pharmaceuticals
7.12.1 Madrigal Pharmaceuticals Details
7.12.2 Madrigal Pharmaceuticals Major Business
7.12.3 Madrigal Pharmaceuticals Vascular Disrupting Agents Product and Services
7.12.4 Madrigal Pharmaceuticals Vascular Disrupting Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Madrigal Pharmaceuticals Recent Developments/Updates
7.12.6 Madrigal Pharmaceuticals Competitive Strengths & Weaknesses
7.13 Celgene Corporation
7.13.1 Celgene Corporation Details
7.13.2 Celgene Corporation Major Business
7.13.3 Celgene Corporation Vascular Disrupting Agents Product and Services
7.13.4 Celgene Corporation Vascular Disrupting Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Celgene Corporation Recent Developments/Updates
7.13.6 Celgene Corporation Competitive Strengths & Weaknesses
7.14 Bionomics
7.14.1 Bionomics Details
7.14.2 Bionomics Major Business
7.14.3 Bionomics Vascular Disrupting Agents Product and Services
7.14.4 Bionomics Vascular Disrupting Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Bionomics Recent Developments/Updates
7.14.6 Bionomics Competitive Strengths & Weaknesses
7.15 Lees Pharmaceutical Holdings
7.15.1 Lees Pharmaceutical Holdings Details
7.15.2 Lees Pharmaceutical Holdings Major Business
7.15.3 Lees Pharmaceutical Holdings Vascular Disrupting Agents Product and Services
7.15.4 Lees Pharmaceutical Holdings Vascular Disrupting Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Lees Pharmaceutical Holdings Recent Developments/Updates
7.15.6 Lees Pharmaceutical Holdings Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Vascular Disrupting Agents Industry Chain
8.2 Vascular Disrupting Agents Upstream Analysis
8.2.1 Vascular Disrupting Agents Core Raw Materials
8.2.2 Main Manufacturers of Vascular Disrupting Agents Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Vascular Disrupting Agents Production Mode
8.6 Vascular Disrupting Agents Procurement Model
8.7 Vascular Disrupting Agents Industry Sales Model and Sales Channels
8.7.1 Vascular Disrupting Agents Sales Model
8.7.2 Vascular Disrupting Agents Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Vascular Disrupting Agents Introduction
1.2 World Vascular Disrupting Agents Supply & Forecast
1.2.1 World Vascular Disrupting Agents Production Value (2018 & 2022 & 2029)
1.2.2 World Vascular Disrupting Agents Production (2018-2029)
1.2.3 World Vascular Disrupting Agents Pricing Trends (2018-2029)
1.3 World Vascular Disrupting Agents Production by Region (Based on Production Site)
1.3.1 World Vascular Disrupting Agents Production Value by Region (2018-2029)
1.3.2 World Vascular Disrupting Agents Production by Region (2018-2029)
1.3.3 World Vascular Disrupting Agents Average Price by Region (2018-2029)
1.3.4 North America Vascular Disrupting Agents Production (2018-2029)
1.3.5 Europe Vascular Disrupting Agents Production (2018-2029)
1.3.6 China Vascular Disrupting Agents Production (2018-2029)
1.3.7 Japan Vascular Disrupting Agents Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Vascular Disrupting Agents Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Vascular Disrupting Agents Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Vascular Disrupting Agents Demand (2018-2029)
2.2 World Vascular Disrupting Agents Consumption by Region
2.2.1 World Vascular Disrupting Agents Consumption by Region (2018-2023)
2.2.2 World Vascular Disrupting Agents Consumption Forecast by Region (2024-2029)
2.3 United States Vascular Disrupting Agents Consumption (2018-2029)
2.4 China Vascular Disrupting Agents Consumption (2018-2029)
2.5 Europe Vascular Disrupting Agents Consumption (2018-2029)
2.6 Japan Vascular Disrupting Agents Consumption (2018-2029)
2.7 South Korea Vascular Disrupting Agents Consumption (2018-2029)
2.8 ASEAN Vascular Disrupting Agents Consumption (2018-2029)
2.9 India Vascular Disrupting Agents Consumption (2018-2029)
3 WORLD VASCULAR DISRUPTING AGENTS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Vascular Disrupting Agents Production Value by Manufacturer (2018-2023)
3.2 World Vascular Disrupting Agents Production by Manufacturer (2018-2023)
3.3 World Vascular Disrupting Agents Average Price by Manufacturer (2018-2023)
3.4 Vascular Disrupting Agents Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Vascular Disrupting Agents Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Vascular Disrupting Agents in 2022
3.5.3 Global Concentration Ratios (CR8) for Vascular Disrupting Agents in 2022
3.6 Vascular Disrupting Agents Market: Overall Company Footprint Analysis
3.6.1 Vascular Disrupting Agents Market: Region Footprint
3.6.2 Vascular Disrupting Agents Market: Company Product Type Footprint
3.6.3 Vascular Disrupting Agents Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Vascular Disrupting Agents Production Value Comparison
4.1.1 United States VS China: Vascular Disrupting Agents Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Vascular Disrupting Agents Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Vascular Disrupting Agents Production Comparison
4.2.1 United States VS China: Vascular Disrupting Agents Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Vascular Disrupting Agents Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Vascular Disrupting Agents Consumption Comparison
4.3.1 United States VS China: Vascular Disrupting Agents Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Vascular Disrupting Agents Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Vascular Disrupting Agents Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Vascular Disrupting Agents Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Vascular Disrupting Agents Production Value (2018-2023)
4.4.3 United States Based Manufacturers Vascular Disrupting Agents Production (2018-2023)
4.5 China Based Vascular Disrupting Agents Manufacturers and Market Share
4.5.1 China Based Vascular Disrupting Agents Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Vascular Disrupting Agents Production Value (2018-2023)
4.5.3 China Based Manufacturers Vascular Disrupting Agents Production (2018-2023)
4.6 Rest of World Based Vascular Disrupting Agents Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Vascular Disrupting Agents Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Vascular Disrupting Agents Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Vascular Disrupting Agents Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Vascular Disrupting Agents Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Oral
5.2.2 Vein
5.3 Market Segment by Type
5.3.1 World Vascular Disrupting Agents Production by Type (2018-2029)
5.3.2 World Vascular Disrupting Agents Production Value by Type (2018-2029)
5.3.3 World Vascular Disrupting Agents Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Vascular Disrupting Agents Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Specialty Clinic
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Vascular Disrupting Agents Production by Application (2018-2029)
6.3.2 World Vascular Disrupting Agents Production Value by Application (2018-2029)
6.3.3 World Vascular Disrupting Agents Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 AGC Biologics
7.1.1 AGC Biologics Details
7.1.2 AGC Biologics Major Business
7.1.3 AGC Biologics Vascular Disrupting Agents Product and Services
7.1.4 AGC Biologics Vascular Disrupting Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 AGC Biologics Recent Developments/Updates
7.1.6 AGC Biologics Competitive Strengths & Weaknesses
7.2 Avid Bioservices
7.2.1 Avid Bioservices Details
7.2.2 Avid Bioservices Major Business
7.2.3 Avid Bioservices Vascular Disrupting Agents Product and Services
7.2.4 Avid Bioservices Vascular Disrupting Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Avid Bioservices Recent Developments/Updates
7.2.6 Avid Bioservices Competitive Strengths & Weaknesses
7.3 Bionomics
7.3.1 Bionomics Details
7.3.2 Bionomics Major Business
7.3.3 Bionomics Vascular Disrupting Agents Product and Services
7.3.4 Bionomics Vascular Disrupting Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Bionomics Recent Developments/Updates
7.3.6 Bionomics Competitive Strengths & Weaknesses
7.4 Beijing Shenogen Biomedical
7.4.1 Beijing Shenogen Biomedical Details
7.4.2 Beijing Shenogen Biomedical Major Business
7.4.3 Beijing Shenogen Biomedical Vascular Disrupting Agents Product and Services
7.4.4 Beijing Shenogen Biomedical Vascular Disrupting Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Beijing Shenogen Biomedical Recent Developments/Updates
7.4.6 Beijing Shenogen Biomedical Competitive Strengths & Weaknesses
7.5 Mateon Therapeutics
7.5.1 Mateon Therapeutics Details
7.5.2 Mateon Therapeutics Major Business
7.5.3 Mateon Therapeutics Vascular Disrupting Agents Product and Services
7.5.4 Mateon Therapeutics Vascular Disrupting Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Mateon Therapeutics Recent Developments/Updates
7.5.6 Mateon Therapeutics Competitive Strengths & Weaknesses
7.6 Myrexis
7.6.1 Myrexis Details
7.6.2 Myrexis Major Business
7.6.3 Myrexis Vascular Disrupting Agents Product and Services
7.6.4 Myrexis Vascular Disrupting Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Myrexis Recent Developments/Updates
7.6.6 Myrexis Competitive Strengths & Weaknesses
7.7 VBL Therapeutics
7.7.1 VBL Therapeutics Details
7.7.2 VBL Therapeutics Major Business
7.7.3 VBL Therapeutics Vascular Disrupting Agents Product and Services
7.7.4 VBL Therapeutics Vascular Disrupting Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 VBL Therapeutics Recent Developments/Updates
7.7.6 VBL Therapeutics Competitive Strengths & Weaknesses
7.8 Steba biotech
7.8.1 Steba biotech Details
7.8.2 Steba biotech Major Business
7.8.3 Steba biotech Vascular Disrupting Agents Product and Services
7.8.4 Steba biotech Vascular Disrupting Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Steba biotech Recent Developments/Updates
7.8.6 Steba biotech Competitive Strengths & Weaknesses
7.9 BeyondSpring Pharmaceutical
7.9.1 BeyondSpring Pharmaceutical Details
7.9.2 BeyondSpring Pharmaceutical Major Business
7.9.3 BeyondSpring Pharmaceutical Vascular Disrupting Agents Product and Services
7.9.4 BeyondSpring Pharmaceutical Vascular Disrupting Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 BeyondSpring Pharmaceutical Recent Developments/Updates
7.9.6 BeyondSpring Pharmaceutical Competitive Strengths & Weaknesses
7.10 Immune Pharmaceuticals
7.10.1 Immune Pharmaceuticals Details
7.10.2 Immune Pharmaceuticals Major Business
7.10.3 Immune Pharmaceuticals Vascular Disrupting Agents Product and Services
7.10.4 Immune Pharmaceuticals Vascular Disrupting Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Immune Pharmaceuticals Recent Developments/Updates
7.10.6 Immune Pharmaceuticals Competitive Strengths & Weaknesses
7.11 Nereus Pharmaceuticals
7.11.1 Nereus Pharmaceuticals Details
7.11.2 Nereus Pharmaceuticals Major Business
7.11.3 Nereus Pharmaceuticals Vascular Disrupting Agents Product and Services
7.11.4 Nereus Pharmaceuticals Vascular Disrupting Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Nereus Pharmaceuticals Recent Developments/Updates
7.11.6 Nereus Pharmaceuticals Competitive Strengths & Weaknesses
7.12 Madrigal Pharmaceuticals
7.12.1 Madrigal Pharmaceuticals Details
7.12.2 Madrigal Pharmaceuticals Major Business
7.12.3 Madrigal Pharmaceuticals Vascular Disrupting Agents Product and Services
7.12.4 Madrigal Pharmaceuticals Vascular Disrupting Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Madrigal Pharmaceuticals Recent Developments/Updates
7.12.6 Madrigal Pharmaceuticals Competitive Strengths & Weaknesses
7.13 Celgene Corporation
7.13.1 Celgene Corporation Details
7.13.2 Celgene Corporation Major Business
7.13.3 Celgene Corporation Vascular Disrupting Agents Product and Services
7.13.4 Celgene Corporation Vascular Disrupting Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Celgene Corporation Recent Developments/Updates
7.13.6 Celgene Corporation Competitive Strengths & Weaknesses
7.14 Bionomics
7.14.1 Bionomics Details
7.14.2 Bionomics Major Business
7.14.3 Bionomics Vascular Disrupting Agents Product and Services
7.14.4 Bionomics Vascular Disrupting Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Bionomics Recent Developments/Updates
7.14.6 Bionomics Competitive Strengths & Weaknesses
7.15 Lees Pharmaceutical Holdings
7.15.1 Lees Pharmaceutical Holdings Details
7.15.2 Lees Pharmaceutical Holdings Major Business
7.15.3 Lees Pharmaceutical Holdings Vascular Disrupting Agents Product and Services
7.15.4 Lees Pharmaceutical Holdings Vascular Disrupting Agents Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Lees Pharmaceutical Holdings Recent Developments/Updates
7.15.6 Lees Pharmaceutical Holdings Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Vascular Disrupting Agents Industry Chain
8.2 Vascular Disrupting Agents Upstream Analysis
8.2.1 Vascular Disrupting Agents Core Raw Materials
8.2.2 Main Manufacturers of Vascular Disrupting Agents Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Vascular Disrupting Agents Production Mode
8.6 Vascular Disrupting Agents Procurement Model
8.7 Vascular Disrupting Agents Industry Sales Model and Sales Channels
8.7.1 Vascular Disrupting Agents Sales Model
8.7.2 Vascular Disrupting Agents Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Vascular Disrupting Agents Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Vascular Disrupting Agents Production Value by Region (2018-2023) & (USD Million)
Table 3. World Vascular Disrupting Agents Production Value by Region (2024-2029) & (USD Million)
Table 4. World Vascular Disrupting Agents Production Value Market Share by Region (2018-2023)
Table 5. World Vascular Disrupting Agents Production Value Market Share by Region (2024-2029)
Table 6. World Vascular Disrupting Agents Production by Region (2018-2023) & (K Units)
Table 7. World Vascular Disrupting Agents Production by Region (2024-2029) & (K Units)
Table 8. World Vascular Disrupting Agents Production Market Share by Region (2018-2023)
Table 9. World Vascular Disrupting Agents Production Market Share by Region (2024-2029)
Table 10. World Vascular Disrupting Agents Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Vascular Disrupting Agents Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Vascular Disrupting Agents Major Market Trends
Table 13. World Vascular Disrupting Agents Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Vascular Disrupting Agents Consumption by Region (2018-2023) & (K Units)
Table 15. World Vascular Disrupting Agents Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Vascular Disrupting Agents Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Vascular Disrupting Agents Producers in 2022
Table 18. World Vascular Disrupting Agents Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Vascular Disrupting Agents Producers in 2022
Table 20. World Vascular Disrupting Agents Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Vascular Disrupting Agents Company Evaluation Quadrant
Table 22. World Vascular Disrupting Agents Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Vascular Disrupting Agents Production Site of Key Manufacturer
Table 24. Vascular Disrupting Agents Market: Company Product Type Footprint
Table 25. Vascular Disrupting Agents Market: Company Product Application Footprint
Table 26. Vascular Disrupting Agents Competitive Factors
Table 27. Vascular Disrupting Agents New Entrant and Capacity Expansion Plans
Table 28. Vascular Disrupting Agents Mergers & Acquisitions Activity
Table 29. United States VS China Vascular Disrupting Agents Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Vascular Disrupting Agents Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Vascular Disrupting Agents Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Vascular Disrupting Agents Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Vascular Disrupting Agents Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Vascular Disrupting Agents Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Vascular Disrupting Agents Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Vascular Disrupting Agents Production Market Share (2018-2023)
Table 37. China Based Vascular Disrupting Agents Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Vascular Disrupting Agents Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Vascular Disrupting Agents Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Vascular Disrupting Agents Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Vascular Disrupting Agents Production Market Share (2018-2023)
Table 42. Rest of World Based Vascular Disrupting Agents Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Vascular Disrupting Agents Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Vascular Disrupting Agents Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Vascular Disrupting Agents Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Vascular Disrupting Agents Production Market Share (2018-2023)
Table 47. World Vascular Disrupting Agents Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Vascular Disrupting Agents Production by Type (2018-2023) & (K Units)
Table 49. World Vascular Disrupting Agents Production by Type (2024-2029) & (K Units)
Table 50. World Vascular Disrupting Agents Production Value by Type (2018-2023) & (USD Million)
Table 51. World Vascular Disrupting Agents Production Value by Type (2024-2029) & (USD Million)
Table 52. World Vascular Disrupting Agents Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Vascular Disrupting Agents Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Vascular Disrupting Agents Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Vascular Disrupting Agents Production by Application (2018-2023) & (K Units)
Table 56. World Vascular Disrupting Agents Production by Application (2024-2029) & (K Units)
Table 57. World Vascular Disrupting Agents Production Value by Application (2018-2023) & (USD Million)
Table 58. World Vascular Disrupting Agents Production Value by Application (2024-2029) & (USD Million)
Table 59. World Vascular Disrupting Agents Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Vascular Disrupting Agents Average Price by Application (2024-2029) & (US$/Unit)
Table 61. AGC Biologics Basic Information, Manufacturing Base and Competitors
Table 62. AGC Biologics Major Business
Table 63. AGC Biologics Vascular Disrupting Agents Product and Services
Table 64. AGC Biologics Vascular Disrupting Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. AGC Biologics Recent Developments/Updates
Table 66. AGC Biologics Competitive Strengths & Weaknesses
Table 67. Avid Bioservices Basic Information, Manufacturing Base and Competitors
Table 68. Avid Bioservices Major Business
Table 69. Avid Bioservices Vascular Disrupting Agents Product and Services
Table 70. Avid Bioservices Vascular Disrupting Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Avid Bioservices Recent Developments/Updates
Table 72. Avid Bioservices Competitive Strengths & Weaknesses
Table 73. Bionomics Basic Information, Manufacturing Base and Competitors
Table 74. Bionomics Major Business
Table 75. Bionomics Vascular Disrupting Agents Product and Services
Table 76. Bionomics Vascular Disrupting Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Bionomics Recent Developments/Updates
Table 78. Bionomics Competitive Strengths & Weaknesses
Table 79. Beijing Shenogen Biomedical Basic Information, Manufacturing Base and Competitors
Table 80. Beijing Shenogen Biomedical Major Business
Table 81. Beijing Shenogen Biomedical Vascular Disrupting Agents Product and Services
Table 82. Beijing Shenogen Biomedical Vascular Disrupting Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Beijing Shenogen Biomedical Recent Developments/Updates
Table 84. Beijing Shenogen Biomedical Competitive Strengths & Weaknesses
Table 85. Mateon Therapeutics Basic Information, Manufacturing Base and Competitors
Table 86. Mateon Therapeutics Major Business
Table 87. Mateon Therapeutics Vascular Disrupting Agents Product and Services
Table 88. Mateon Therapeutics Vascular Disrupting Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Mateon Therapeutics Recent Developments/Updates
Table 90. Mateon Therapeutics Competitive Strengths & Weaknesses
Table 91. Myrexis Basic Information, Manufacturing Base and Competitors
Table 92. Myrexis Major Business
Table 93. Myrexis Vascular Disrupting Agents Product and Services
Table 94. Myrexis Vascular Disrupting Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Myrexis Recent Developments/Updates
Table 96. Myrexis Competitive Strengths & Weaknesses
Table 97. VBL Therapeutics Basic Information, Manufacturing Base and Competitors
Table 98. VBL Therapeutics Major Business
Table 99. VBL Therapeutics Vascular Disrupting Agents Product and Services
Table 100. VBL Therapeutics Vascular Disrupting Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. VBL Therapeutics Recent Developments/Updates
Table 102. VBL Therapeutics Competitive Strengths & Weaknesses
Table 103. Steba biotech Basic Information, Manufacturing Base and Competitors
Table 104. Steba biotech Major Business
Table 105. Steba biotech Vascular Disrupting Agents Product and Services
Table 106. Steba biotech Vascular Disrupting Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Steba biotech Recent Developments/Updates
Table 108. Steba biotech Competitive Strengths & Weaknesses
Table 109. BeyondSpring Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 110. BeyondSpring Pharmaceutical Major Business
Table 111. BeyondSpring Pharmaceutical Vascular Disrupting Agents Product and Services
Table 112. BeyondSpring Pharmaceutical Vascular Disrupting Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. BeyondSpring Pharmaceutical Recent Developments/Updates
Table 114. BeyondSpring Pharmaceutical Competitive Strengths & Weaknesses
Table 115. Immune Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 116. Immune Pharmaceuticals Major Business
Table 117. Immune Pharmaceuticals Vascular Disrupting Agents Product and Services
Table 118. Immune Pharmaceuticals Vascular Disrupting Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Immune Pharmaceuticals Recent Developments/Updates
Table 120. Immune Pharmaceuticals Competitive Strengths & Weaknesses
Table 121. Nereus Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 122. Nereus Pharmaceuticals Major Business
Table 123. Nereus Pharmaceuticals Vascular Disrupting Agents Product and Services
Table 124. Nereus Pharmaceuticals Vascular Disrupting Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Nereus Pharmaceuticals Recent Developments/Updates
Table 126. Nereus Pharmaceuticals Competitive Strengths & Weaknesses
Table 127. Madrigal Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 128. Madrigal Pharmaceuticals Major Business
Table 129. Madrigal Pharmaceuticals Vascular Disrupting Agents Product and Services
Table 130. Madrigal Pharmaceuticals Vascular Disrupting Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Madrigal Pharmaceuticals Recent Developments/Updates
Table 132. Madrigal Pharmaceuticals Competitive Strengths & Weaknesses
Table 133. Celgene Corporation Basic Information, Manufacturing Base and Competitors
Table 134. Celgene Corporation Major Business
Table 135. Celgene Corporation Vascular Disrupting Agents Product and Services
Table 136. Celgene Corporation Vascular Disrupting Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Celgene Corporation Recent Developments/Updates
Table 138. Celgene Corporation Competitive Strengths & Weaknesses
Table 139. Bionomics Basic Information, Manufacturing Base and Competitors
Table 140. Bionomics Major Business
Table 141. Bionomics Vascular Disrupting Agents Product and Services
Table 142. Bionomics Vascular Disrupting Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Bionomics Recent Developments/Updates
Table 144. Lees Pharmaceutical Holdings Basic Information, Manufacturing Base and Competitors
Table 145. Lees Pharmaceutical Holdings Major Business
Table 146. Lees Pharmaceutical Holdings Vascular Disrupting Agents Product and Services
Table 147. Lees Pharmaceutical Holdings Vascular Disrupting Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 148. Global Key Players of Vascular Disrupting Agents Upstream (Raw Materials)
Table 149. Vascular Disrupting Agents Typical Customers
Table 150. Vascular Disrupting Agents Typical Distributors
Table 1. World Vascular Disrupting Agents Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Vascular Disrupting Agents Production Value by Region (2018-2023) & (USD Million)
Table 3. World Vascular Disrupting Agents Production Value by Region (2024-2029) & (USD Million)
Table 4. World Vascular Disrupting Agents Production Value Market Share by Region (2018-2023)
Table 5. World Vascular Disrupting Agents Production Value Market Share by Region (2024-2029)
Table 6. World Vascular Disrupting Agents Production by Region (2018-2023) & (K Units)
Table 7. World Vascular Disrupting Agents Production by Region (2024-2029) & (K Units)
Table 8. World Vascular Disrupting Agents Production Market Share by Region (2018-2023)
Table 9. World Vascular Disrupting Agents Production Market Share by Region (2024-2029)
Table 10. World Vascular Disrupting Agents Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Vascular Disrupting Agents Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Vascular Disrupting Agents Major Market Trends
Table 13. World Vascular Disrupting Agents Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Vascular Disrupting Agents Consumption by Region (2018-2023) & (K Units)
Table 15. World Vascular Disrupting Agents Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Vascular Disrupting Agents Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Vascular Disrupting Agents Producers in 2022
Table 18. World Vascular Disrupting Agents Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Vascular Disrupting Agents Producers in 2022
Table 20. World Vascular Disrupting Agents Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Vascular Disrupting Agents Company Evaluation Quadrant
Table 22. World Vascular Disrupting Agents Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Vascular Disrupting Agents Production Site of Key Manufacturer
Table 24. Vascular Disrupting Agents Market: Company Product Type Footprint
Table 25. Vascular Disrupting Agents Market: Company Product Application Footprint
Table 26. Vascular Disrupting Agents Competitive Factors
Table 27. Vascular Disrupting Agents New Entrant and Capacity Expansion Plans
Table 28. Vascular Disrupting Agents Mergers & Acquisitions Activity
Table 29. United States VS China Vascular Disrupting Agents Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Vascular Disrupting Agents Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Vascular Disrupting Agents Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Vascular Disrupting Agents Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Vascular Disrupting Agents Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Vascular Disrupting Agents Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Vascular Disrupting Agents Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Vascular Disrupting Agents Production Market Share (2018-2023)
Table 37. China Based Vascular Disrupting Agents Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Vascular Disrupting Agents Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Vascular Disrupting Agents Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Vascular Disrupting Agents Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Vascular Disrupting Agents Production Market Share (2018-2023)
Table 42. Rest of World Based Vascular Disrupting Agents Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Vascular Disrupting Agents Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Vascular Disrupting Agents Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Vascular Disrupting Agents Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Vascular Disrupting Agents Production Market Share (2018-2023)
Table 47. World Vascular Disrupting Agents Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Vascular Disrupting Agents Production by Type (2018-2023) & (K Units)
Table 49. World Vascular Disrupting Agents Production by Type (2024-2029) & (K Units)
Table 50. World Vascular Disrupting Agents Production Value by Type (2018-2023) & (USD Million)
Table 51. World Vascular Disrupting Agents Production Value by Type (2024-2029) & (USD Million)
Table 52. World Vascular Disrupting Agents Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Vascular Disrupting Agents Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Vascular Disrupting Agents Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Vascular Disrupting Agents Production by Application (2018-2023) & (K Units)
Table 56. World Vascular Disrupting Agents Production by Application (2024-2029) & (K Units)
Table 57. World Vascular Disrupting Agents Production Value by Application (2018-2023) & (USD Million)
Table 58. World Vascular Disrupting Agents Production Value by Application (2024-2029) & (USD Million)
Table 59. World Vascular Disrupting Agents Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Vascular Disrupting Agents Average Price by Application (2024-2029) & (US$/Unit)
Table 61. AGC Biologics Basic Information, Manufacturing Base and Competitors
Table 62. AGC Biologics Major Business
Table 63. AGC Biologics Vascular Disrupting Agents Product and Services
Table 64. AGC Biologics Vascular Disrupting Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. AGC Biologics Recent Developments/Updates
Table 66. AGC Biologics Competitive Strengths & Weaknesses
Table 67. Avid Bioservices Basic Information, Manufacturing Base and Competitors
Table 68. Avid Bioservices Major Business
Table 69. Avid Bioservices Vascular Disrupting Agents Product and Services
Table 70. Avid Bioservices Vascular Disrupting Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Avid Bioservices Recent Developments/Updates
Table 72. Avid Bioservices Competitive Strengths & Weaknesses
Table 73. Bionomics Basic Information, Manufacturing Base and Competitors
Table 74. Bionomics Major Business
Table 75. Bionomics Vascular Disrupting Agents Product and Services
Table 76. Bionomics Vascular Disrupting Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Bionomics Recent Developments/Updates
Table 78. Bionomics Competitive Strengths & Weaknesses
Table 79. Beijing Shenogen Biomedical Basic Information, Manufacturing Base and Competitors
Table 80. Beijing Shenogen Biomedical Major Business
Table 81. Beijing Shenogen Biomedical Vascular Disrupting Agents Product and Services
Table 82. Beijing Shenogen Biomedical Vascular Disrupting Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Beijing Shenogen Biomedical Recent Developments/Updates
Table 84. Beijing Shenogen Biomedical Competitive Strengths & Weaknesses
Table 85. Mateon Therapeutics Basic Information, Manufacturing Base and Competitors
Table 86. Mateon Therapeutics Major Business
Table 87. Mateon Therapeutics Vascular Disrupting Agents Product and Services
Table 88. Mateon Therapeutics Vascular Disrupting Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Mateon Therapeutics Recent Developments/Updates
Table 90. Mateon Therapeutics Competitive Strengths & Weaknesses
Table 91. Myrexis Basic Information, Manufacturing Base and Competitors
Table 92. Myrexis Major Business
Table 93. Myrexis Vascular Disrupting Agents Product and Services
Table 94. Myrexis Vascular Disrupting Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Myrexis Recent Developments/Updates
Table 96. Myrexis Competitive Strengths & Weaknesses
Table 97. VBL Therapeutics Basic Information, Manufacturing Base and Competitors
Table 98. VBL Therapeutics Major Business
Table 99. VBL Therapeutics Vascular Disrupting Agents Product and Services
Table 100. VBL Therapeutics Vascular Disrupting Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. VBL Therapeutics Recent Developments/Updates
Table 102. VBL Therapeutics Competitive Strengths & Weaknesses
Table 103. Steba biotech Basic Information, Manufacturing Base and Competitors
Table 104. Steba biotech Major Business
Table 105. Steba biotech Vascular Disrupting Agents Product and Services
Table 106. Steba biotech Vascular Disrupting Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Steba biotech Recent Developments/Updates
Table 108. Steba biotech Competitive Strengths & Weaknesses
Table 109. BeyondSpring Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 110. BeyondSpring Pharmaceutical Major Business
Table 111. BeyondSpring Pharmaceutical Vascular Disrupting Agents Product and Services
Table 112. BeyondSpring Pharmaceutical Vascular Disrupting Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. BeyondSpring Pharmaceutical Recent Developments/Updates
Table 114. BeyondSpring Pharmaceutical Competitive Strengths & Weaknesses
Table 115. Immune Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 116. Immune Pharmaceuticals Major Business
Table 117. Immune Pharmaceuticals Vascular Disrupting Agents Product and Services
Table 118. Immune Pharmaceuticals Vascular Disrupting Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Immune Pharmaceuticals Recent Developments/Updates
Table 120. Immune Pharmaceuticals Competitive Strengths & Weaknesses
Table 121. Nereus Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 122. Nereus Pharmaceuticals Major Business
Table 123. Nereus Pharmaceuticals Vascular Disrupting Agents Product and Services
Table 124. Nereus Pharmaceuticals Vascular Disrupting Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Nereus Pharmaceuticals Recent Developments/Updates
Table 126. Nereus Pharmaceuticals Competitive Strengths & Weaknesses
Table 127. Madrigal Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 128. Madrigal Pharmaceuticals Major Business
Table 129. Madrigal Pharmaceuticals Vascular Disrupting Agents Product and Services
Table 130. Madrigal Pharmaceuticals Vascular Disrupting Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Madrigal Pharmaceuticals Recent Developments/Updates
Table 132. Madrigal Pharmaceuticals Competitive Strengths & Weaknesses
Table 133. Celgene Corporation Basic Information, Manufacturing Base and Competitors
Table 134. Celgene Corporation Major Business
Table 135. Celgene Corporation Vascular Disrupting Agents Product and Services
Table 136. Celgene Corporation Vascular Disrupting Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Celgene Corporation Recent Developments/Updates
Table 138. Celgene Corporation Competitive Strengths & Weaknesses
Table 139. Bionomics Basic Information, Manufacturing Base and Competitors
Table 140. Bionomics Major Business
Table 141. Bionomics Vascular Disrupting Agents Product and Services
Table 142. Bionomics Vascular Disrupting Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Bionomics Recent Developments/Updates
Table 144. Lees Pharmaceutical Holdings Basic Information, Manufacturing Base and Competitors
Table 145. Lees Pharmaceutical Holdings Major Business
Table 146. Lees Pharmaceutical Holdings Vascular Disrupting Agents Product and Services
Table 147. Lees Pharmaceutical Holdings Vascular Disrupting Agents Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 148. Global Key Players of Vascular Disrupting Agents Upstream (Raw Materials)
Table 149. Vascular Disrupting Agents Typical Customers
Table 150. Vascular Disrupting Agents Typical Distributors
LIST OF FIGURES
Figure 1. Vascular Disrupting Agents Picture
Figure 2. World Vascular Disrupting Agents Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Vascular Disrupting Agents Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Vascular Disrupting Agents Production (2018-2029) & (K Units)
Figure 5. World Vascular Disrupting Agents Average Price (2018-2029) & (US$/Unit)
Figure 6. World Vascular Disrupting Agents Production Value Market Share by Region (2018-2029)
Figure 7. World Vascular Disrupting Agents Production Market Share by Region (2018-2029)
Figure 8. North America Vascular Disrupting Agents Production (2018-2029) & (K Units)
Figure 9. Europe Vascular Disrupting Agents Production (2018-2029) & (K Units)
Figure 10. China Vascular Disrupting Agents Production (2018-2029) & (K Units)
Figure 11. Japan Vascular Disrupting Agents Production (2018-2029) & (K Units)
Figure 12. Vascular Disrupting Agents Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Vascular Disrupting Agents Consumption (2018-2029) & (K Units)
Figure 15. World Vascular Disrupting Agents Consumption Market Share by Region (2018-2029)
Figure 16. United States Vascular Disrupting Agents Consumption (2018-2029) & (K Units)
Figure 17. China Vascular Disrupting Agents Consumption (2018-2029) & (K Units)
Figure 18. Europe Vascular Disrupting Agents Consumption (2018-2029) & (K Units)
Figure 19. Japan Vascular Disrupting Agents Consumption (2018-2029) & (K Units)
Figure 20. South Korea Vascular Disrupting Agents Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Vascular Disrupting Agents Consumption (2018-2029) & (K Units)
Figure 22. India Vascular Disrupting Agents Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Vascular Disrupting Agents by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Vascular Disrupting Agents Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Vascular Disrupting Agents Markets in 2022
Figure 26. United States VS China: Vascular Disrupting Agents Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Vascular Disrupting Agents Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Vascular Disrupting Agents Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Vascular Disrupting Agents Production Market Share 2022
Figure 30. China Based Manufacturers Vascular Disrupting Agents Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Vascular Disrupting Agents Production Market Share 2022
Figure 32. World Vascular Disrupting Agents Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Vascular Disrupting Agents Production Value Market Share by Type in 2022
Figure 34. Oral
Figure 35. Vein
Figure 36. World Vascular Disrupting Agents Production Market Share by Type (2018-2029)
Figure 37. World Vascular Disrupting Agents Production Value Market Share by Type (2018-2029)
Figure 38. World Vascular Disrupting Agents Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Vascular Disrupting Agents Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Vascular Disrupting Agents Production Value Market Share by Application in 2022
Figure 41. Hospital
Figure 42. Specialty Clinic
Figure 43. Others
Figure 44. World Vascular Disrupting Agents Production Market Share by Application (2018-2029)
Figure 45. World Vascular Disrupting Agents Production Value Market Share by Application (2018-2029)
Figure 46. World Vascular Disrupting Agents Average Price by Application (2018-2029) & (US$/Unit)
Figure 47. Vascular Disrupting Agents Industry Chain
Figure 48. Vascular Disrupting Agents Procurement Model
Figure 49. Vascular Disrupting Agents Sales Model
Figure 50. Vascular Disrupting Agents Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
Figure 1. Vascular Disrupting Agents Picture
Figure 2. World Vascular Disrupting Agents Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Vascular Disrupting Agents Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Vascular Disrupting Agents Production (2018-2029) & (K Units)
Figure 5. World Vascular Disrupting Agents Average Price (2018-2029) & (US$/Unit)
Figure 6. World Vascular Disrupting Agents Production Value Market Share by Region (2018-2029)
Figure 7. World Vascular Disrupting Agents Production Market Share by Region (2018-2029)
Figure 8. North America Vascular Disrupting Agents Production (2018-2029) & (K Units)
Figure 9. Europe Vascular Disrupting Agents Production (2018-2029) & (K Units)
Figure 10. China Vascular Disrupting Agents Production (2018-2029) & (K Units)
Figure 11. Japan Vascular Disrupting Agents Production (2018-2029) & (K Units)
Figure 12. Vascular Disrupting Agents Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Vascular Disrupting Agents Consumption (2018-2029) & (K Units)
Figure 15. World Vascular Disrupting Agents Consumption Market Share by Region (2018-2029)
Figure 16. United States Vascular Disrupting Agents Consumption (2018-2029) & (K Units)
Figure 17. China Vascular Disrupting Agents Consumption (2018-2029) & (K Units)
Figure 18. Europe Vascular Disrupting Agents Consumption (2018-2029) & (K Units)
Figure 19. Japan Vascular Disrupting Agents Consumption (2018-2029) & (K Units)
Figure 20. South Korea Vascular Disrupting Agents Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Vascular Disrupting Agents Consumption (2018-2029) & (K Units)
Figure 22. India Vascular Disrupting Agents Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Vascular Disrupting Agents by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Vascular Disrupting Agents Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Vascular Disrupting Agents Markets in 2022
Figure 26. United States VS China: Vascular Disrupting Agents Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Vascular Disrupting Agents Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Vascular Disrupting Agents Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Vascular Disrupting Agents Production Market Share 2022
Figure 30. China Based Manufacturers Vascular Disrupting Agents Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Vascular Disrupting Agents Production Market Share 2022
Figure 32. World Vascular Disrupting Agents Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Vascular Disrupting Agents Production Value Market Share by Type in 2022
Figure 34. Oral
Figure 35. Vein
Figure 36. World Vascular Disrupting Agents Production Market Share by Type (2018-2029)
Figure 37. World Vascular Disrupting Agents Production Value Market Share by Type (2018-2029)
Figure 38. World Vascular Disrupting Agents Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Vascular Disrupting Agents Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Vascular Disrupting Agents Production Value Market Share by Application in 2022
Figure 41. Hospital
Figure 42. Specialty Clinic
Figure 43. Others
Figure 44. World Vascular Disrupting Agents Production Market Share by Application (2018-2029)
Figure 45. World Vascular Disrupting Agents Production Value Market Share by Application (2018-2029)
Figure 46. World Vascular Disrupting Agents Average Price by Application (2018-2029) & (US$/Unit)
Figure 47. Vascular Disrupting Agents Industry Chain
Figure 48. Vascular Disrupting Agents Procurement Model
Figure 49. Vascular Disrupting Agents Sales Model
Figure 50. Vascular Disrupting Agents Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
